HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of differentiation of WEHI-3B D+ leukemic cells transfected with differentiation-stimulating factor/leukemia inhibitory factor receptor cDNA.

Abstract
Differentiation-stimulating factor (D-factor)/leukemia inhibitory factor can induce the differentiation of mouse myeloid leukemia M1 cells and also stimulate proliferation of the interleukin-3 (IL-3)-dependent cell line, DA-1a. To determine whether D-factor can induce the differentiation of leukemia cells other than M1 cells, WEHI-3B D+ mouse myelomonocytic leukemia cells were transfected with a plasmid containing mouse D-factor receptor cDNA. Expression of D-factor receptor in transfected cells was determined by binding of [125]D-factor and analyzed by Scatchard's method. The transfected cells had high-affinity D-factor receptors with a dissociation constant of 100 to 200 pmol/L and binding sites per cell varied from 67 to 1,500 among several clones. The cells expressing a high level of D-factor receptor were induced to differentiate by D-factor; about 60% of the cells exhibited the ability to reduce nitroblue tetrazolium and expression of the differentiation antigen Mac-1 (CD11b) on the cell surface increased. The effect of cytokines, which induce the differentiation of M1 cells, on the transfected WEHI-3B cells was examined. The sensitivity to oncostatin M was identical to that against D-factor in the cells of each clone. Expression of D-factor receptor in WEHI-3B cells promoted sensitivity to IL-6 and granulocyte colony-stimulating factor (G-CSF). Induction of differentiation of the cells accompanied the suppression of proliferation. Treatment of the cells with D-factor for longer than 5 days resulted in 50% inhibition of growth. These results indicate that the stimulating effect of D-factor on the differentiation of malignant myeloid cells is not unique to M1 cells.
AuthorsM Tomida
JournalBlood (Blood) Vol. 85 Issue 1 Pg. 217-21 (Jan 01 1995) ISSN: 0006-4971 [Print] United States
PMID7528568 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Complementary
  • Growth Inhibitors
  • Interleukin-6
  • Leukemia Inhibitory Factor
  • Leukemia Inhibitory Factor Receptor alpha Subunit
  • Lif protein, mouse
  • Lifr protein, mouse
  • Lymphokines
  • Macrophage-1 Antigen
  • Osm protein, mouse
  • Peptides
  • Receptors, Cytokine
  • Receptors, OSM-LIF
  • Oncostatin M
  • Granulocyte Colony-Stimulating Factor
  • Nitroblue Tetrazolium
Topics
  • Animals
  • Cell Differentiation
  • Cell Division
  • DNA, Complementary (genetics)
  • Granulocyte Colony-Stimulating Factor (pharmacology)
  • Growth Inhibitors (metabolism, pharmacology)
  • Interleukin-6 (pharmacology)
  • Leukemia Inhibitory Factor
  • Leukemia Inhibitory Factor Receptor alpha Subunit
  • Leukemia, Myelomonocytic, Chronic (metabolism, pathology)
  • Lymphokines (metabolism, pharmacology)
  • Macrophage-1 Antigen (metabolism)
  • Mice
  • Nitroblue Tetrazolium (metabolism)
  • Oncostatin M
  • Peptides (pharmacology)
  • Receptors, Cytokine (genetics, physiology)
  • Receptors, OSM-LIF
  • Transfection
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: